Enhanc3D Genomics Launches 3D Multi-Omic Solutions to Transform Drug Discovery

Enhanc3D Genomics has unveiled a groundbreaking suite of integrated multi-omics solutions designed to revolutionize drug discovery and development. Leveraging the company’s proprietary 3D genomics platform and extensive multi-omics analysis, these new offerings provide a comprehensive end-to-end solution to support informed decision-making at every stage of the drug development process.

At the core of the platform is patented Promoter Capture Hi-C technology, which enables the creation of high-resolution, genome-wide regulatory maps. These maps capture interactions between promoters and regulatory regions, delivering unparalleled insights into genomic activity. By integrating this data with the 3D Multi-Omic Atlas, a vast repository of multi-omic data across human cell types, the platform uncovers deep insights into disease mechanisms and therapeutic opportunities, paving the way for precision-driven drug discovery.